Showing results (1641-1650 of 2,362) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|January 1, 1989
Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-upJ I Hudson, H G Pope, P E Keck, et al.Clinical Neuropharmacology|March 12, 2016
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple SclerosisBoyd M Koffman, Miles Hacker, William T Gunning, et al.Clinical Neuropharmacology|March 12, 2016
Treating Schizophrenia With the Diuretic Bumetanide: A Case ReportEric Lemonnier, Alain Lazartigues, Yehezkel Ben-AriClinical Neuropharmacology|November 5, 2015
Rotigotine Transdermal Patch Does Not Make Parkinson Disease Patients Sleepy During DaytimeKouichi Ohta, Takashi OsadaClinical Neuropharmacology|November 5, 2015
Recurrent and Alternating Pisa SyndromeAlejandro Pellene, Michel Saenz-Farret, Federico MicheliClinical Neuropharmacology|January 1, 1986
Etiology of Parkinson's disease: current conceptsR C DuvoisinClinical Neuropharmacology|November 9, 2013
Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case seriesKentaro Kawabe, Fumie Horiuchi, Shu-ichi UenoClinical Neuropharmacology|June 1, 1988
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's diseaseA Lieberman, L Chin, G BaumannClinical Neuropharmacology|July 20, 2018
Fluoxetine-Induced Skin Picking and Compulsive Behaviors in a Preschool GirlFatma Çoşkun, Ayhan BilgiçClinical Neuropharmacology|July 20, 2018
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect RelationshipManuela Contin, Luca Mancinelli, Alessandro Perrone, et al.Pageof 237